TA
NVO

TFB Advisors’s Novo Nordisk NVO Stock Holding History

TFB Advisors’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-2,479
Closed -$213K – 330
2024
Q4 		$213K Sell
2,479
-709
-22% -$76.7K 0.06% 305
2024
Q3 		$380K Sell
3,188
-88
-3% -$11.7K 0.11% 201
2024
Q2 		$468K Buy
3,276
+684
+26% +$90.6K 0.15% 153
2024
Q1 		$335K Buy
+2,592
New +$309K 0.12% 185
2023
Q3 		– Sell
-2,542
Closed -$206K – 186
2023
Q2 		$206K Buy
+2,542
New +$208K 0.09% 221

Other funds holding NVO

Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
TIM
Thornburg Investment Management Santa Fe, New Mexico $9.63B AUM 35.65% 1-Year Est. Return

TFB Advisors's NVO Position: Q1 2025 in Review

TFB Advisors sold out of Novo Nordisk (NVO) in Q1 2025, closing a stake of 2,479 shares — an estimated $213K sold.

TFB Advisors first reported a position in NVO in Q2 2023 and held it in 5 quarters. The position peaked at $468K in Q2 2024. 1,528 funds tracked by Wall St. Rank hold NVO as of Q1 2025.

  • TFB Advisors reported no remaining Novo Nordisk position as of Q1 2025 after selling out during the quarter.
  • TFB Advisors sold 2,479 Novo Nordisk shares in Q1 2025, an estimated $213K.
  • TFB Advisors first reported a position in Novo Nordisk in Q2 2023 and held it in 5 quarters.
  • TFB Advisors's Novo Nordisk position peaked at $468K in Q2 2024.
  • 1,528 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2025.

Based on TFB Advisors's 13F filing for Q1 2025, filed 14 May 2025.